Report - Sekundärprävention von TVT/LE - aerzteverein.de · NOAs reduced VTE recurrence rates from 7.24% with placebo to 1.32% New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban,

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form